Joint presentation to Fx Conference Audio Conference on Digital Health, May 21, 2013. My part focused on FDA regulation of mobile medical applications.
DoD/VA mHealth 2013 returns on November 18-20, 2013 for its second annual mobile health event, a collaborative summit dedicated to advancing and supporting mobile health initiatives in the Departments of Defense and Veterans Affairs.
This event will showcase the latest military medical technologies, regulations, applications and security. In-depth sessions will include a focus day and 2 main session days covering critical topics such as: Streamlining DoD Health IT Infrastructure, Integrating Medical Information through mHealth, Improving User Engagement through the Use of Mobile Applications, and Combating Traumatic Brain Injury through mHealth.
mHealth Israel_Technology, Data & Medical Technologies- the Perfect Storm_Bos...Levi Shapiro
Presentation by Jonathan Goldstein, Director, Corporate R&D and Venture at Boston Scientific on November 5th, 2020. Covers the historical progression of transformational technological disruption and the opportunities in cardiac devices. These include heart failure products, proctoring in pacemakers as well as Clinical Data and Big Data.
Healthcare in Blockchain overview by Lea Dias, CEO, Quaefacta, November 11, 2020. Key use cases include the following:
1) PHARMA & MEDICAL DEVICES SUPPLY CHAIN TRACEABILITY
2) MEDICAL RECORDS INTEROPERABILITY
3) DIGITAL IDENTITY
4) CLINICAL TRIALS VERIFICATION
5) GENOMICS DATA SEQUENCING
eHealth - Medical Systems Interoperability & Mobile Healthulmedical
The Medical Device industry is rapidly adopting technologies that enable communication and connectivity of health products and systems to improve both speed and quality of care as well as patient safety. The users (i.e. hospitals and others) are demanding an approach that will support interoperability among multiple independently sourced medical devices. Industry will require standardization to support such interoperability. Government and regulators, on behalf of the patients and in compliance with their mission to protect public health, as well as users and manufacturers require that such interoperability is safe. This complementary webinar will introduce the eHealth sector and applications, outline the challenges and risks inherent in connecting heterogeneous equipment into medical device systems, and provide insights to how manufacturers can demonstrate compliance with the rapidly changing regulatory landscape for interoperable medical devices.
This webinar was presented by UL eHealth experts on October 30, 2013.
David Farber (http://bit.ly/2DFnvJ1), Head of the FDA and Reimbursement Practice at King & Spalding in Washington DC, leads a workshop for medtech and digital health companies seeking US reimbursement. He brings 30+ years of experience in US Healthcare reimbursement, lobbying and FDA regulatory issues. In addition to ongoing reimbursement challenges, 2020 will see a fundamental transformation in US medical reimbursement (http://bit.ly/2YWlYbt), particularly in digital health. That includes 394 Current Procedural Terminology (CPT) code changes, 248 new codes, 71 deletions and 75 revisions
DoD/VA mHealth 2013 returns on November 18-20, 2013 for its second annual mobile health event, a collaborative summit dedicated to advancing and supporting mobile health initiatives in the Departments of Defense and Veterans Affairs.
This event will showcase the latest military medical technologies, regulations, applications and security. In-depth sessions will include a focus day and 2 main session days covering critical topics such as: Streamlining DoD Health IT Infrastructure, Integrating Medical Information through mHealth, Improving User Engagement through the Use of Mobile Applications, and Combating Traumatic Brain Injury through mHealth.
mHealth Israel_Technology, Data & Medical Technologies- the Perfect Storm_Bos...Levi Shapiro
Presentation by Jonathan Goldstein, Director, Corporate R&D and Venture at Boston Scientific on November 5th, 2020. Covers the historical progression of transformational technological disruption and the opportunities in cardiac devices. These include heart failure products, proctoring in pacemakers as well as Clinical Data and Big Data.
Healthcare in Blockchain overview by Lea Dias, CEO, Quaefacta, November 11, 2020. Key use cases include the following:
1) PHARMA & MEDICAL DEVICES SUPPLY CHAIN TRACEABILITY
2) MEDICAL RECORDS INTEROPERABILITY
3) DIGITAL IDENTITY
4) CLINICAL TRIALS VERIFICATION
5) GENOMICS DATA SEQUENCING
eHealth - Medical Systems Interoperability & Mobile Healthulmedical
The Medical Device industry is rapidly adopting technologies that enable communication and connectivity of health products and systems to improve both speed and quality of care as well as patient safety. The users (i.e. hospitals and others) are demanding an approach that will support interoperability among multiple independently sourced medical devices. Industry will require standardization to support such interoperability. Government and regulators, on behalf of the patients and in compliance with their mission to protect public health, as well as users and manufacturers require that such interoperability is safe. This complementary webinar will introduce the eHealth sector and applications, outline the challenges and risks inherent in connecting heterogeneous equipment into medical device systems, and provide insights to how manufacturers can demonstrate compliance with the rapidly changing regulatory landscape for interoperable medical devices.
This webinar was presented by UL eHealth experts on October 30, 2013.
David Farber (http://bit.ly/2DFnvJ1), Head of the FDA and Reimbursement Practice at King & Spalding in Washington DC, leads a workshop for medtech and digital health companies seeking US reimbursement. He brings 30+ years of experience in US Healthcare reimbursement, lobbying and FDA regulatory issues. In addition to ongoing reimbursement challenges, 2020 will see a fundamental transformation in US medical reimbursement (http://bit.ly/2YWlYbt), particularly in digital health. That includes 394 Current Procedural Terminology (CPT) code changes, 248 new codes, 71 deletions and 75 revisions
A governance model for ubiquitous medical devices accessing eHealth data: the...Massimiliano Masi
The Electronic Health Record (EHR) is a reality in almost all the EU and USA regions.
The introduction of EHR dramatically reduced the need for paper-based records, thus resulting in an improvement of patient care, including the “freedom of movement” principle across countries. EHRs contain very sensitive information (Private Healthcare Information, PHI) and they are ruled by several acts and international regulations, defined by each country. Key principles for this sector are interoperability, and security. There are two overarching standards for such security, FHIR and IHE. This short presentation aims at providing an overall status across eHealth Security and Interoperability, common pitfalls, and a description of common architectures, when connecting medical devices to patient’s EHR.
Protecting Privacy, Security and Patient Safety in mHealthTAOklahoma
Patricia D. King, J.D., M.B.A.
Associate General Counsel
Swedish Covenant Hospital
Oklahoma Telemedicine Conference 2014: Telehealth Transition
October 16, 2014
Global interventional cardiology market 2017-2022 sample reportNetscribes, Inc.
Interventional cardiology is the catheter-based treatment of cardiovascular diseases. Certified cardiologists who perform these procedures are known as intervention cardiologists.
https://www.researchonglobalmarkets.com/global-interventional-cardiology-market-2014-2022.html
For the full report please write to info@netscribes.com
The term “wireless” in Industry 4.0 is not limited to only wireless communication; it is backed up by modern technologies such as the Internet of Things (IoT) and Cloud Computing for effective and robust system functionality. In the health and medical domain, medical devices are labeled as wireless medical devices when the device itself, or a part of the device, fulfills a health service using wireless communication protocols. Indeed, since patient care and safety are the highest priorities, these devices should follow FDA safety guidelines before they are released in the market...
The global Telehealth market is estimated to be valued at USD 25.30 billion in 2022, growing at a CAGR of 14% during 2014-2022.
https://www.researchonglobalmarkets.com/global-telehealth-market-2014-2022.html
For the full report please write to info@netscribes.com
TeleHealth: Today and Tomorrow - Some BasicsRon Huber
Basics of TeleHealth as a primer for TeleHealth: Today and Tomorrow meetup. http://www.digitalhealthinnovationsd.com/2016/05/02/telehealth-today-and-tomorrow/
Presentation about transparency under the new MDR and IVDR at Informa Medtech Summit in Clinical evaluations and investigations for medical devices track
Use of left over samples under the IVDR and GDPRErik Vollebregt
Presentation on the RAPS Convergence 2017 about the use of left over samples in performance evaluation under the In Vitro Diagnostics Regulation (IVDR) and under the General Data Protection Regulation (GDPR)
In accordance with the overall Elliot Project spirit, the Bulgarian Internet of Things eHealth case will also apply the Living Lab methodology, will use some elements of Cloud Computing, and will rely on a Web Intelligence system, which will consist of 7 parts: medical algorithms; expert systems; BI (Business Intelligent) system; databases; notification system; doctors’ Operational Advisory Portal and Patients’ Prevention Advisory Portal.
Leveraging emerging standards for patient engagement pchamHealth2015
Patients are playing an increasingly important role in creating relevant healthcare data about themselves using mobile devices and applications. It is important this data can move with them securely throughout a healthcare ecosystem. The increased use of medical devices and mobile applications opens the dialogue around open source and non-proprietary standards with complementing policies.
A governance model for ubiquitous medical devices accessing eHealth data: the...Massimiliano Masi
The Electronic Health Record (EHR) is a reality in almost all the EU and USA regions.
The introduction of EHR dramatically reduced the need for paper-based records, thus resulting in an improvement of patient care, including the “freedom of movement” principle across countries. EHRs contain very sensitive information (Private Healthcare Information, PHI) and they are ruled by several acts and international regulations, defined by each country. Key principles for this sector are interoperability, and security. There are two overarching standards for such security, FHIR and IHE. This short presentation aims at providing an overall status across eHealth Security and Interoperability, common pitfalls, and a description of common architectures, when connecting medical devices to patient’s EHR.
Protecting Privacy, Security and Patient Safety in mHealthTAOklahoma
Patricia D. King, J.D., M.B.A.
Associate General Counsel
Swedish Covenant Hospital
Oklahoma Telemedicine Conference 2014: Telehealth Transition
October 16, 2014
Global interventional cardiology market 2017-2022 sample reportNetscribes, Inc.
Interventional cardiology is the catheter-based treatment of cardiovascular diseases. Certified cardiologists who perform these procedures are known as intervention cardiologists.
https://www.researchonglobalmarkets.com/global-interventional-cardiology-market-2014-2022.html
For the full report please write to info@netscribes.com
The term “wireless” in Industry 4.0 is not limited to only wireless communication; it is backed up by modern technologies such as the Internet of Things (IoT) and Cloud Computing for effective and robust system functionality. In the health and medical domain, medical devices are labeled as wireless medical devices when the device itself, or a part of the device, fulfills a health service using wireless communication protocols. Indeed, since patient care and safety are the highest priorities, these devices should follow FDA safety guidelines before they are released in the market...
The global Telehealth market is estimated to be valued at USD 25.30 billion in 2022, growing at a CAGR of 14% during 2014-2022.
https://www.researchonglobalmarkets.com/global-telehealth-market-2014-2022.html
For the full report please write to info@netscribes.com
TeleHealth: Today and Tomorrow - Some BasicsRon Huber
Basics of TeleHealth as a primer for TeleHealth: Today and Tomorrow meetup. http://www.digitalhealthinnovationsd.com/2016/05/02/telehealth-today-and-tomorrow/
Presentation about transparency under the new MDR and IVDR at Informa Medtech Summit in Clinical evaluations and investigations for medical devices track
Use of left over samples under the IVDR and GDPRErik Vollebregt
Presentation on the RAPS Convergence 2017 about the use of left over samples in performance evaluation under the In Vitro Diagnostics Regulation (IVDR) and under the General Data Protection Regulation (GDPR)
In accordance with the overall Elliot Project spirit, the Bulgarian Internet of Things eHealth case will also apply the Living Lab methodology, will use some elements of Cloud Computing, and will rely on a Web Intelligence system, which will consist of 7 parts: medical algorithms; expert systems; BI (Business Intelligent) system; databases; notification system; doctors’ Operational Advisory Portal and Patients’ Prevention Advisory Portal.
Leveraging emerging standards for patient engagement pchamHealth2015
Patients are playing an increasingly important role in creating relevant healthcare data about themselves using mobile devices and applications. It is important this data can move with them securely throughout a healthcare ecosystem. The increased use of medical devices and mobile applications opens the dialogue around open source and non-proprietary standards with complementing policies.
Title: The mHealth Policy Conundrum: Keeping Pace with Technology
Description: In the fourth session attendees will be provided an update on changes to policy which impact the mobile and wireless space. Topics addressed include finalization of the FDA Safety and Innovation Act (FDASIA) Workgroup. Other major policy changes implemented in 2014 and potential future changes over 2015 include updates to the Physician Fee Schedule, legislative efforts improving the use and definition of Telemedicine.
Speakers: Robert Jarrin & Brian Balow
Objectives: Identify current policy issues which impact mHealth adoption. Describe the impacts of FDA regulation. Discuss opportunities for policy improvement.
Deployed eHealth solutions in Morocco_ ELKAFIL_MOROCCO.pptxHORIYASOFT
Second Workshop of the North African eHealth Hub , “Towards eHealth policy roadmap and implementation plan“May 12-13, 2022, Hammamet -TUNISIA- Deployed ehalth solutions in morocco by abdrahman elkafil (Moroccan Society in Telemedicine and ehealth)
Scenario:
Midwest Regional Health is one of Wisconsin's largest and most sophisticated hospitals, is Implementing a new EHR system that will better their services to their internal and external customers. They are asking ITMC (I-Tech Medical Consortium) to help them navigate through this long term project, thereby improving their commitment to their surrounding community.
Presentation: Device vigilance - local challenges & global trendsTGA Australia
This session will examine some of the hot topic in this areas including a presentation from TGA covering some of the challenges they are seeing locally as well as an industry perspective on global hot topics and trends in device vigilance
Telecommunication systems applied to telemedicineShazia Iqbal
Telemedicine allows health care professionals to evaluate, diagnose and treat patients at a distance using telecommunications technology.
The approach has been through a striking evolution in the last decade and it is becoming an increasingly important.
Mobile devices are enforcing its use in all aspects of life, health care is one major area where mobile device could enhance operations, or improve quality and efficincy. Here is a presentation I gave at HIMSS which may be useful to you if you are considering using mobile device in your health care discpline.
Opening Keynote: The Convergence of mHealth: A Consumer and Clinical Perspective
Description: In the opening keynote attendees will hear an overview from a current HIMSS mHealth Community Member which sets the stage for discussion. The keynote will highlight facts and figures which support the thesis of increased utilization of mobile and wireless technologies by healthcare providers. The keynote will also set the stage with current issues impacting the continued adoption.
Speaker(s): Ahmed Albaiti
Objectives: Assess the current landscape of mHealth. Illustrate the roles of consumers and patients. Define the current issues.
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Andrew Hooge, Val...HxRefactored
Through new telehealth technologies and increased data analysis physicians are gaining insights into patients like never before, allowing them to facilitate early interventions, improve adherence, and reduce readmission rates -- not to mention at a price more affordable than ever. The companies you’ll hear from in this session are using a healthy and innovative mix of data, educational tools, sensors, and more to improve patient outcomes.
System Request FormDateProject Name Centralizing Medic.docxmattinsonjanel
System Request Form
Date:
Project Name: Centralizing Medical Information To Improve patient Care
Project Sponsor:
Name: Team
Department:Healthcare
Organization:Hospitals
Contact Information: Phone:
Business Problem Statement: Christine Newton
The American Recovery and Reinvestment Act of 2009 were established to interoperable health information technology and qualified electronic health records. Doctors and patients need accurate information to improve the outcome of medical care for proper diagnosis and patients need access to their information regardless of the doctor they choose to visit. The solution to this is a centralized national database system which makes diagnosis and treatment easier for doctors and patients. The centralized database system would allow the focus on patient care instead of the monetization of the care by providing vital medical information necessary to expedite diagnosis.Accurate medical history and quick access to this information is a vital part of patient care for emergency which could save lives, provide medical advances with data analysis and increased diagnosis efficiency.An infrastructure to allow health information exchange between non-affiliated hospitals that participate in Medicaid/Medicare which would allow privacy, provide critical information and improve efficiency would provide this solution.
High-Level Functional Requirements:
Automation of process for maintaining medical records:
1. Access medical information through Pin Number.
1. Provide access of medical information within health care facilities.
1. Access medical information from scanning health card via magnetic strip, or barcode
1. Information that can be accessed could include known allergies, current and past medical conditions.
1. Provide secure way of accessing information, i.e. encryption.
1. Provide for the ability to update and add information in real time.
1. Granting appropriate permissions to Doctors, Paramedics, Patients, etc.
1. Patient authorizes medical personnel access to medical records per HIPAA regulations.
1. Track prescription via medications paid for by Medicaid insurance
High-Level Proposed
Solution
and Business Benefits:
The solution for this type of system is barcode or magnetic strip on insurance cards which would retrieve patient medical. When scanned, important medical information will be readily available to doctors or emergency personnel. This information can then be linked to a centralized database for all hospitals which would be housed by government entity. Currently Medicare/Medicaid hospitals that are nonaffiliated do not have access to customer’s information even though they accept Medicaid; by incorporating a centralized database that each hospital can retrieve information via customer consent with pin number or insurance magnetic strip would resolve this issue.
The main benefits of this system to the government areincrease efficiency, increase productivity, improved diagnosis, decrea ...
GMP Review -- Legal Letter from America Column -- How Data Integrity Issues S...Michael Swit
Article appearing in the October 2018 issue of GMP Review by Michael A. Swit explores how data integrity issues sunk a $4.3 billion acquisition of Akorn by Fresenius. Article stresses lessons not just for quality professionals, but also their top management.
FDA Regulation of Promotion & Advertising -- Part 8: Handling Promotional Com...Michael Swit
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices,November 2, 2018, Boston.
FDA Regulation of Promotion & Advertising -- Part 7: FTC RegulationMichael Swit
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices,
FDA Regulation of Promotion & Advertising -- Part 6: First Amendment, Off-Lab...Michael Swit
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices, November 2, 2018, Boston.
FDA Regulation of Promotion & Advertising -- Part 5: Social Media & InternetMichael Swit
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices, November 1-2, 2018, Boston
FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement – Action...Michael Swit
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices, November 1-2, 2018, Boston.
FDA Regulation of Promotion & Advertising -- Part 3: Disseminating Scientific...Michael Swit
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices, November 1-2, 2018, Boston
FDA Regulation of Promotion & Advertising --Part 2: Direct-to-Consumer AdsMichael Swit
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices,November 1-2, 2018, Boston
FDA Regulation of Promotion & Advertising -- Part 1: The BasicsMichael Swit
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices, November 1-2, 2018, Boston.
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...Michael Swit
Supporting Materials for Michael Swit's Panel remarks at the Workshop Co-sponsored by the Orange County Regulatory Affairs (OCRA) Discussion Group and the Small Business Development Center (SBDC) @ UCI Applied Innovation
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...Michael Swit
June 23, 2010 webinar sponsored by The Weinberg Group, with an emphasis on key issues to explore during due diligence in acquiring FDA-regulated products or companies.
Presentation on Critical Legal Issues Facing GMP ComplianceMichael Swit
August 27, 2018 Presentation to the 23rd Annual GMP by the Sea Conference in Cambridge, Maryland, focusing on the potential legal consequences faced by companies that violate FDA's requirements on Good Manufacturing Practices (GMPs) for drugs and biologics
Overview of FDA Drug Manufacturing RequirementsMichael Swit
Presentation on FDA Regulation of Drug Manufacturing to the Introduction to Drug Law Course sponsored by the Food & Drug Law Institute (FDLI) on July 25, 2018 in San Francisco.
Combination Products, Orphan Drugs, and OTC DrugsMichael Swit
Presentation to the San Diego Regulatory Affairs Network (SDRAN) Regulatory Affairs Certification (RAC) Exam review course on FDA regulation of combination products, orphan drugs, and OTC drugs.
Latest Developments in and the Future of the Regulatory Landscape for Approv...Michael Swit
Presentation on "Latest Developments in and the Future of the
Regulatory Landscape for Approving Treatments
for Orphan and Rare Diseases," given at the Orphan Drugs & Rare Diseases -- 2018 Americas West Coast Conference.
June 25, 2018. San Diego, CA.
How to Obtain Permanent Residency in the NetherlandsBridgeWest.eu
You can rely on our assistance if you are ready to apply for permanent residency. Find out more at: https://immigration-netherlands.com/obtain-a-permanent-residence-permit-in-the-netherlands/.
WINDING UP of COMPANY, Modes of DissolutionKHURRAMWALI
Winding up, also known as liquidation, refers to the legal and financial process of dissolving a company. It involves ceasing operations, selling assets, settling debts, and ultimately removing the company from the official business registry.
Here's a breakdown of the key aspects of winding up:
Reasons for Winding Up:
Insolvency: This is the most common reason, where the company cannot pay its debts. Creditors may initiate a compulsory winding up to recover their dues.
Voluntary Closure: The owners may decide to close the company due to reasons like reaching business goals, facing losses, or merging with another company.
Deadlock: If shareholders or directors cannot agree on how to run the company, a court may order a winding up.
Types of Winding Up:
Voluntary Winding Up: This is initiated by the company's shareholders through a resolution passed by a majority vote. There are two main types:
Members' Voluntary Winding Up: The company is solvent (has enough assets to pay off its debts) and shareholders will receive any remaining assets after debts are settled.
Creditors' Voluntary Winding Up: The company is insolvent and creditors will be prioritized in receiving payment from the sale of assets.
Compulsory Winding Up: This is initiated by a court order, typically at the request of creditors, government agencies, or even by the company itself if it's insolvent.
Process of Winding Up:
Appointment of Liquidator: A qualified professional is appointed to oversee the winding-up process. They are responsible for selling assets, paying off debts, and distributing any remaining funds.
Cease Trading: The company stops its regular business operations.
Notification of Creditors: Creditors are informed about the winding up and invited to submit their claims.
Sale of Assets: The company's assets are sold to generate cash to pay off creditors.
Payment of Debts: Creditors are paid according to a set order of priority, with secured creditors receiving payment before unsecured creditors.
Distribution to Shareholders: If there are any remaining funds after all debts are settled, they are distributed to shareholders according to their ownership stake.
Dissolution: Once all claims are settled and distributions made, the company is officially dissolved and removed from the business register.
Impact of Winding Up:
Employees: Employees will likely lose their jobs during the winding-up process.
Creditors: Creditors may not recover their debts in full, especially if the company is insolvent.
Shareholders: Shareholders may not receive any payout if the company's debts exceed its assets.
Winding up is a complex legal and financial process that can have significant consequences for all parties involved. It's important to seek professional legal and financial advice when considering winding up a company.
In 2020, the Ministry of Home Affairs established a committee led by Prof. (Dr.) Ranbir Singh, former Vice Chancellor of National Law University (NLU), Delhi. This committee was tasked with reviewing the three codes of criminal law. The primary objective of the committee was to propose comprehensive reforms to the country’s criminal laws in a manner that is both principled and effective.
The committee’s focus was on ensuring the safety and security of individuals, communities, and the nation as a whole. Throughout its deliberations, the committee aimed to uphold constitutional values such as justice, dignity, and the intrinsic value of each individual. Their goal was to recommend amendments to the criminal laws that align with these values and priorities.
Subsequently, in February, the committee successfully submitted its recommendations regarding amendments to the criminal law. These recommendations are intended to serve as a foundation for enhancing the current legal framework, promoting safety and security, and upholding the constitutional principles of justice, dignity, and the inherent worth of every individual.
ALL EYES ON RAFAH BUT WHY Explain more.pdf46adnanshahzad
All eyes on Rafah: But why?. The Rafah border crossing, a crucial point between Egypt and the Gaza Strip, often finds itself at the center of global attention. As we explore the significance of Rafah, we’ll uncover why all eyes are on Rafah and the complexities surrounding this pivotal region.
INTRODUCTION
What makes Rafah so significant that it captures global attention? The phrase ‘All eyes are on Rafah’ resonates not just with those in the region but with people worldwide who recognize its strategic, humanitarian, and political importance. In this guide, we will delve into the factors that make Rafah a focal point for international interest, examining its historical context, humanitarian challenges, and political dimensions.
Responsibilities of the office bearers while registering multi-state cooperat...Finlaw Consultancy Pvt Ltd
Introduction-
The process of register multi-state cooperative society in India is governed by the Multi-State Co-operative Societies Act, 2002. This process requires the office bearers to undertake several crucial responsibilities to ensure compliance with legal and regulatory frameworks. The key office bearers typically include the President, Secretary, and Treasurer, along with other elected members of the managing committee. Their responsibilities encompass administrative, legal, and financial duties essential for the successful registration and operation of the society.
NATURE, ORIGIN AND DEVELOPMENT OF INTERNATIONAL LAW.pptxanvithaav
These slides helps the student of international law to understand what is the nature of international law? and how international law was originated and developed?.
The slides was well structured along with the highlighted points for better understanding .
2. www.duanemorris.com
Standard Disclaimers
• Views expressed here are solely ours and
do not reflect those of our firm or any of its
clients.
• This presentation supports an oral briefing
and should not be relied upon solely on its
own to support any conclusion of law or
fact.
• This presentation, and the materials
included herewith, are provided for general
educational purposes and should not be
construed as legal advice.
2
3. www.duanemorris.com
What We Will Cover
• Background on mHealth – Lisa Clark
• The FCC and mHealth – Ken Keane
• FDA and mHealth – Michael Swit
• Privacy and Security/HIPAA and mHealth –
Lisa Clark
3
5. www.duanemorris.com
What is mHealth? Terms and
Definitions
• mHealth
– is health care delivered wirelessly
– facilitates health data exchange
– is replacing bricks-and-mortar health care delivery
• Closely related term: Health Information
Technology (HIT)
• Other terms: Telemedicine, Telehealth, Wireless
Health, eHealth, Digital Health
5
6. www.duanemorris.com
mHealth Devices and Platforms
• Medical devices:
– Glucose meters that transmit results to electronic
health record (EHR) or lab
– Wearable devices to track patients who may wander
• Medical apps/software
– Tablet or smart phone with app that provides general
medical information to physicians at bedside
• Other software
– Software that supports health information exchanges
(HIEs) and electronic health records (EHRs)
6
8. www.duanemorris.com
The mHealth Stakeholders
1. Device makers, pharma
2. Start-ups, etc.
3. Investors
4. Payors
5. Providers
6. Consumers
7. Government
8. Others:
1. Standard setting organization, academia, telecom, private
organizations
8
9. www.duanemorris.com
Expected Growth in mHealth
• Anticipated growth:
– $27.3B by 2016 (BCC Research)
– Growth rate at 22% through 2014 (RNCOS)
• Simultaneous contraction in hospital-based
and other traditional healthcare services
(physician visits, etc.).
9
10. www.duanemorris.com
• Federal Communications Commission (FCC)
• Food & Drug Administration (FDA)
• Health and Human Services (HHS)
– Office of the National Coordinator (ONC)
– Centers for Medicare and Medicaid Services (CMS)
• Federal Trade Commission (FTC)
• Other
– Department of Homeland Security
– Department of Commerce (National Telecommunications and
Information Administration)
– States, etc.
10
Who is Regulating mHealth?
11. www.duanemorris.com
mHealth/Government Interest
• Government -- actively tracking mHealth and
HIT and why, where, and how to jump in.
– 62 government committees (!) looking at mHealth/HIT.
• Congress – three days of hearings in mid-
March 2013
11
12. www.duanemorris.com
mHealth/Government Interest …
• The Food and Drug Administration Safety
Innovation Act (FDASIA) Workgroup:
– “charged with providing expert input on issues and concepts
identified by the Food and Drug Administration (FDA), Office of the
National Coordinator for Health IT (ONC), and the Federal
Communications Commission (FCC) to in order to inform the
development of a report on an appropriate, risk-based regulatory
framework pertaining to health information technology including
mobile medical applications that promotes innovation, protects
patient safety, and avoids regulatory duplication.”
– First meeting was on April 29, 2013. Slides from meeting are at
www.healthit.gov/sites/default/files/fdasia_kickoff_faca_slides.pdf
12
13. www.duanemorris.com
mHealth/This Presentation
• We will review key mHealth activities regarding
– FCC
– FDA
– Privacy and security/HIPAA
• Other areas of interest include (not discussed today)
– Reimbursement (Medicare, Medicaid and private)
– Fraud and abuse
– Licensure
– Liability/insurance/malpractice
– IP
13
15. www.duanemorris.com
FCC -- History in Wireless Medical
Technology
• Allocated spectrum for low-power medical
telemetry 40 years ago
• 460-470 MHz
• Unlicensed medical applications also long allowed
under FCC Rules
• In 1999, established rules for implanted
devices like wireless defibrillators (aka
Medical Implant Communications Service or
“MICS”)
• 402-405 MHz15
16. www.duanemorris.com
FCC – History with Wireless Medical …
• In 2000, designated 14 MHz for Wireless
Medical Telemetry
• 608-614 MHz and 1.4 GHz range
• Used for telemetering patient monitoring data to
central stations
• In 2009, established Medical Device
Radiocommunication Service (“MedRadio”)
• Incorporated MICS and expanded allocation to include
401-406 MHz
• Expanded rule to accommodate body-worn devices.
• Rules harmonized with those in other Regions of the
world16
17. www.duanemorris.com
FCC – History with Wireless Medical …
• Applications include e.g. blood glucose monitors, and
body-worn devices
• In 2010, FCC signed Memorandum of Understanding
with FDA. Intended to increase efficiency of
regulatory processes for wireless medical devices
by, e.g.
• Enhancing information sharing
• Coordinating approval processes
17
18. www.duanemorris.com
FCC – History with Wireless Medical …
• In 2011, rules adopted for Medical
Micropower Networks
• Implanted devices surgically injected to provide
artificial nervous system for stroke victims, wounded
soldiers, and others with traumatic brain injuries
• Spectrum allocated in response to Petition by Alfred
Mann Foundation
• 24 MHz in four six megahertz blocks in UHF band
18
19. www.duanemorris.com
MBAN Devices -- Background
• In 2012, adopted rules for Medical Body
Area Network Systems (“MBAN”)
• Wireless devices for a wide variety of functions such as
blood pressure monitoring, delivery of electrocardiogram
readings, and neonatal monitoring
• MBAN devices designed to be deployed widely within a
hospital setting and make use of inexpensive, disposable
(band-aid sized) body-worn sensors/transmitters
• MBAN technology to facilitate movement of patients to
different parts of the health care facility for treatment, and
reduce risk of infection from wired sensors
19
20. www.duanemorris.com
• limitations of physical cables keep nearly half of all
patients from being actively monitored. MBANs allow
for ubiquitous and reliable monitoring, and give health
care providers the chance to identify life-threatening
problems or events before they occur
• According to Institute for Healthcare Improvement, a
monitored hospital patient has a 48% chance of
surviving a cardiac arrest -- number drops to 6% without
monitoring
20
MBAN Devices -- Background (con’t)
21. www.duanemorris.com
MBAN Rules
• MBAN decision allocated 40 MHz of spectrum at
2360-2400 MHz for MBAN use on a secondary basis
• Expansion of existing MedRadio Service in Part 95 of Rules
• Permits MBAN devices to operate on a ‘license-by-rule’ basis in
which users will not have to apply for and receive individual
station licenses
• Expected to lead to rapid and widespread development of
innovative MBAN applications
21
22. www.duanemorris.com
MBAN Rules (con’t)
• MBAN to share spectrum with primary aviation
users, industry and Government. Rules contain
registration and coordination provisions to protect
flight test telemetry operations conducted by
aerospace companies and government users.
• 2360-2390 MHz long used exclusively for flight test telemetry
between aircraft under test and engineers on the ground
• Enables engineers to monitor performance of aircraft in real-
time, and warn pilot in the event of any anomalous condition is
detected
• Utilizes large, dish-type tracking antennas which are very
sensitive to interference
22
24. www.duanemorris.com
MBAN Rules (con’t)
• While registration with a medical coordinator will be
required, vast majority of MBAN systems in 2360-
2390 MHz will not require coordination with flight
test operations due to geographic separation
• Use of 2360-2390 MHz restricted to indoor operation
at health care facilities at 1 mW
• MBAN devices in the 2390-2400 MHz band will also
share spectrum, but will not require coordination,
and may be used in any location -- including in
residential settings and ambulances -- and at higher
power (20 mW). However, 10 MHz likely not
sufficient in hospital settings.
24
25. www.duanemorris.com
Registration/Coordination Process:
• Hospital will register with an “MBANs coordinator.”
• MBANs coordinator analyzes proposal and provides
data on proposed deployment to aerospace
coordinator
• In the great majority of cases, there will not be any
interference risk, and coordination not necessary
• In cases where analysis shows a risk of
interference, aerospace and medical coordinators
will seek to resolve situation so as to facilitate
successful deployment without risk of interference
to flight testing
25
26. www.duanemorris.com
Registration/Coordination Process
(con’t)
• Upon successful coordination, medical coordinator
will issue hospital an “electronic key” allowing
activation of MBAN systems
• Beacons in hospitals ensure MBAN systems do not
operate out-of-doors in 2360-2390 MHz band
• In the unlikely event of interference to flight test
telemetry, MBANs must immediately shut down
26
27. www.duanemorris.com
Registration/Coordination Process
(con’t)
• As part of the registration process for operating
MBAN devices in the 2360-2390 MHz band, hospital
will provide medical coordinator with a point of
contact responsible for making changes to MBAN
operating parameters (such as discontinuing
operations or changing frequencies)
• Most MBAN systems expected to be capable of
defaulting to 2390-2400 MHz band
• FCC expects its licensees to work together to
resolve any instances of harmful interference
27
28. www.duanemorris.com
Current MBAN Status
• When FCC issued decision, certain issues identified
for further comment. Those issues included, in
particular, selection of a medical coordinator or
coordinators for MBANs.
• Aerospace industry coordinator already designated,
i.e. AFTRCC (association of aerospace companies)*
___________________________
* Duane Morris is counsel for AFTRCC.
28
29. www.duanemorris.com
Current MBAN Status (con’t)
• AFTRCC, GE Healthcare, and Philips Healthcare
have filed Joint Petition for Reconsideration
regarding issues where the Commission departed
from the proposed rules that the parties had
negotiated and presented
• Petition proposes a number of changes to more closely align
FCC rules with IEEE standards
• One issue is eligibility for 2360-2390 MHz, i.e. Commission’s
decision to allow all clinics, no matter how small, to utilize
MBANs devices in this band
29
30. www.duanemorris.com
Current MBAN Status (con’t)
• Petitioners have urged that MBAN systems be limited to
hospitals and other health care facilities which offer patient
beds on a 24-hour basis. Small clinics, which do not need 30
MHz, could use 2390-2400 MHz
• Decision probable by year end
30
31. www.duanemorris.com
Other FCC Activity
• June 2012, FCC established mHealth Task Force
• September 2012, Task Force issued Report
• FCC Chairman Genachowski announced steps that
FCC will take to implement key recommendations in
Task Force Report including:
• Streamlining experimental licensing rules to permit easier
testing of mHealth devices
• Reform of Rural Health Care Program to facilitate broadband
connections, especially in rural areas (decision issued in
December)
31
32. www.duanemorris.com
Other FCC Activity (con’t)
• Directed FCC’s International Bureau to work with regulators in
other countries to encourage making spectrum available for
MBANs and to discuss spectrum harmonization
• Determined to hire Health Care Director who would act as
POC on all health-related issues (now on board)
* * *
32
34. www.duanemorris.com
What is a Medical Device?
• “Device” – Section 201(h) of the Federal Food,
Drug, and Cosmetic Act (the Act): means:
– an instrument, apparatus, implement, machine, contrivance,
implant, in vitro reagent, or other similar or related article,
including any component, part, or accessory, which is—
recognized in the official National Formulary, or the United States
Pharmacopeia, or any supplement to them,
intended for use in the diagnosis of disease or other conditions, or in the cure,
mitigation, treatment, or prevention of disease, in man or other animals, or
intended to affect the structure or any function of the body of man or other
animals, and
which does not achieve its primary intended purposes through chemical
action within or on the body of man or other animals and which is not
dependent upon being metabolized for the achievement of its primary
intended purposes.
34
35. www.duanemorris.com
Is Software a Medical Device?
• Yes, if it fits the definition of Section 201(h),
where the main focus will be how the software
can be used to treat, prevent or diagnose
disease
35
36. www.duanemorris.com
FDA – Basics of Device Regulation
• Devices are classified per risk – 3 Classes
– Class I – least risky; typically do not require prior FDA
review or approval, but must meet all other “general
controls” applicable to all medical devices (e.g., facility
registration, device listing, MDR reports)
– Class II – more risky – typically require FDA clearance
of a “Premarket Notification” Submission or “510(k)”
Standard for clearance of 510(k) – “substantial
equivalence” to an already lawfully marketed device
36
37. www.duanemorris.com
FDA – Basics of Device Regulation
– Class III – most risky – require approval of a
Premarket Approval Application (PMA) –
Standard of approval – reasonable assurance of safety
and effectiveness, based on clinical investigations
• Classification – required of all devices on market
as of May 1976; over 1,000 devices classified as
to:
– Identification – i.e., what is the device?
– Intended use
– Technological characteristics
37
38. www.duanemorris.com
Key to FDA Device Marketing
• Must find a classification that your device
meets
– If not, and your device is new technology, by operation
of law, your device is automatically placed in Class III
• Device “classification” and mHealth Devices –
– Is your product a device at all?
Even if it is, if the use is so “minor,” will FDA allow me to
come to market easily?
If it is, finding a device classification that your mHealth
device meets
– If you can’t, what do you do about being automatically
placed in Class III?38
39. www.duanemorris.com
FDA’s Draft Guidance on Mobile
Medical Applications
• July 2011 – in reply to concerns about FDA
regulation of mobile apps, agency issues draft
guidance
– http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/Gui
danceDocuments/UCM263366.pdf
– “mobile app" -- defined as a software application that
can be executed (run) on a mobile platform, or a web-
based software application that is tailored to a mobile
platform, but is executed on a server.
39
40. www.duanemorris.com
FDA’s Draft Guidance on Mobile
Medical Applications …
– “mobile medical application” (MMA) -- mobile app that
meets the definition of "device" in section 201(h) of the
Federal Food, Drug, and Cosmetic Act (FD&C Act) and
either:
is used as an accessory to a regulated medical device;
or
transforms a mobile platform into a regulated medical
device.
– Intended use – is key to determining if it is a medical
device; can be inferred by FDA from many sources
– Others – FDA will not enforce at this time
40
41. www.duanemorris.com
Draft Guidance – NOT an MMA
• Electronic copies of textbooks, teaching aids, or
reference materials
• General health & wellness apps -- solely used to
log, record, track, evaluate, or make decisions or
suggestions related to developing or maintaining
general health and wellness
– e.g. – dietary tracking logs; appointment reminders;
dietary suggestions based on calorie counting
• Automated office functions – e.g., billing,
inventory
41
42. www.duanemorris.com
Draft Guidance – NOT an MMA …
• Generic aids -- that assist users but are not
commercially marketed for a specific medical
indication.
– e.g., apps that use the mobile platform as a magnifying
glass (but not specifically for medical purposes),
recording audio, note-taking, replaying audio with
amplification, and other similar functionalities.
• Mobile apps that perform the functionality of an
electronic health record system or personal
health record system.
42
43. www.duanemorris.com
Draft Guidance – Apps FDA Will
Regulate
• Apps that are an extension of one or more
medical device(s) by connecting to such
device(s) for purposes of controlling the device(s)
or displaying, storing, analyzing, or transmitting
patient-specific medical device data.
– Examples – are considered “accessories”
remote display of data from bedside monitors
display of medical images
remote control of drug delivery of an infusion pump
– Take on classification of device to which connected
43
44. www.duanemorris.com
Draft Guidance – Apps FDA Will
Regulate …
• Apps that transform the mobile platform into a
medical device by using attachments, display
screens, or sensors or by including functionalities
similar to those of currently regulated medical
devices.
– Example: AliveCor™ iPhone based ECG system –
physical attachment to an iPhone that converts it into
an ECG and transmits data via web
510(k) cleared in November 2012
44
45. www.duanemorris.com
Draft Guidance – Apps FDA Will
Regulate …
• Apps that allow the user to input patient-specific
information and - using formulae or processing
algorithms - output a patient-specific result,
diagnosis, or treatment recommendation to be
used in clinical practice or to assist in making
clinical decisions.
45
46. www.duanemorris.com
Why mHealth and FDA Don’t “Connect”
• Lack of Transparency –
– While FDA says it has reviewed and cleared/approved
over 75 mHealth devices, not clear what FDA required
as 2011 draft guidance is “generic” in nature
no specific guidances for clearances
difficult to find detailed info on “per device” requirements
• Many mHealth Devices do not fit existing
device classifications
– Result – automatic Class III status under law
Challenge – de novo petition process is unwieldy
46
47. www.duanemorris.com
Why mHealth and FDA Don’t “Connect”
• Need for more guidance
– 2011 Guidance – said more guidance would be
provided to cover:
Apps that use data from more than one kind of medical
device
Clinical decision support software
Wireless safety considerations – for example, rumor that
at least one FDAer involved in mHealth issues would
require that developers prove their apps not interfere
with other devices used in healthcare settings
Application of Quality System Regulation (QSR) to
software
47
50. www.duanemorris.com
How it Came to Market
• Classification – 21 CFR 870.2340
Electrocardiograph.
– (a) Identification. An electrocardiograph is a device
used to process the electrical signal transmitted
through two or more electrocardiograph electrodes and
to produce a visual display of the electrical signal
produced by the heart.
– (b) Classification. Class II (performance standards).
• Seven consensus standards and an FDA
guidance document apply – check “Product
Code” to figure that out – “DPS”
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=666
50
51. www.duanemorris.com
So, What Do You Do?
• Meet with FDA – unless absolutely clear
• Understand that you are in the medical device
business and that, even if you have a Class I
device, you have to meet the General
Controls, which are demanding, especially:
– Quality Systems Regulations
Design controls for software
• Reimbursement – who will pay for it?
– CMS
– Private payer
51
53. www.duanemorris.com
Privacy and Security
• The question: What are the required,
recommended and best privacy and security
protections for a particular mHealth product or
service?
– Is the product/service subject to HIPAA?
– Does the FTC guidance apply? Has the FTC initiated an
enforcement action against a similar product/service?
– When is consent to collect/use/disclose data required?
– What other federal or state laws or agencies might regulate the
product/service?
– What are industry best-practices?
53
54. www.duanemorris.com
Privacy and Security
• The terms:
– ‘Privacy’: protects the consumer through
policies, rights to data, etc.
– ‘Security’: protects the data through
passwords, encryption, etc.
– ‘By Design’: Designing the
product/service with privacy and security
in mind
54
55. www.duanemorris.com
Privacy and Security
• The principal laws and regulations:
– Health Information Portability and Accountability Act of
1996 (HIPAA)
– Federal Trade Commission Act (consumer fraud,
fairness)
– Federal and state consent laws
– Other privacy and breach laws
– American Reinvestment and Recovery Act –
Meaningful Use regulations
55
56. www.duanemorris.com
Privacy and Security
• HIPAA:
– Protects the privacy and security of protected health
information (PHI)
– Fines up to $1.5m per year for violations.
– Does HIPAA apply?
Applies to Covered Entities – 1) health care providers
that engage in certain electronic transactions, 2) health
plans, and 3) health clearinghouses (billing companies)
Also applies to Business Associates – agents and
subcontractors of Covered Entities that handle PHI, and
their agents and subcontractors
56
57. www.duanemorris.com
Privacy and Security, HIPAA cont.
• If an entity is not a Covered Entity or Business
Associate, then HIPAA does not apply
– a physician IS a covered entity (and so any app
provided by the physician to patients, e.g., personal
health record that interfaces with physician is covered)
– a data management company that provides services to
a hospital IS a Business Associate
57
58. www.duanemorris.com
Privacy and Security, HIPAA cont.
• A wireless heart rate monitor service provider that permits a
patient to collect heart rate data at home and send it to his/her
physician
• is NOT a Covered Entity if it does not bill a payor (instead bills the
customer or the provider)
• BUT the physician (who is a Covered Entity) must protect the PHI
• Software that supports the distribution of specialized drugs to a
hospital and include a patient portal provides billing services
• IS a Covered Entity if it bills a payor for the hospital or
individual
• IS also a Business Associate because if it is billing for the
hospital or performing data analysis
• MAY BE a Covered Entity as a Provider
58
59. www.duanemorris.com
Privacy and Security, HIPAA cont.
• If HIPAA applies, then must implement a
Compliance Program that includes:
– Privacy requirements – Notices, P&Ps,
Training, Rights for Individuals, etc.
– Security ‘standards’ – Access Restrictions,
Audit Requirements, Disaster Recovery, etc.
– Breach Notification – Breach Reporting Policy
59
60. www.duanemorris.com
Privacy and Security, FTC
• FTC is authorized to protect the consumer
against
– 1) Deception (material misrepresentation, omission);
– 2) Unfairness (harm or the potential for harm)
• Actions:
– PATH social networking app: settled with FTC for
$800k against charges that it deceived users by
collecting personal information from their mobile device
address books without their knowledge and consent.
– AcneApp: agreed to stop advertising baseless claims
that app could cure acne with lights emitted from
smartphones60
61. www.duanemorris.com
Privacy and Security, FTC Guidance
• “Marketing Your Mobile App: Get It Right from
the Start” business.ftc.gov/documents/bus81-
marketing-your-mobile-app
Privacy by Design - Build privacy considerations in from the
start.
Transparency.
Collect sensitive data with consent.
Keep data secure.
Truthful advertising, etc.
- “Mobile Privacy Disclosures: Building Trust Through Transparency”
www.ftc.gov/os/2013/02/130201mobileprivacyreport.pdf
61
62. www.duanemorris.com
Privacy and Security, FTC Guidance
• “Mobile App Developers: Start with
Security” business.ftc.gov/documents/bus83-mobile-app-
developers-start-security
– Make someone responsible.
– Take stock of the data.
– Understand differences between mobile platforms.
– Use due diligence on third party code.
– Use transit encryption for usernames, passwords, and other
important data.
– Protect your services, etc.
62
63. www.duanemorris.com
Privacy and Security, Sensitive Data
and Consent
• When is consent to collect/use/disclose
‘sensitive data’ required?
– ‘Sensitive data’ includes: mental health, substance
abuse, reproductive health, genetic, infectious disease
and other data.
– Different laws apply.
– Consent may be obtained in writing, through opt-in/opt-
out, etc. – verbal not advised.
– Consent must be clear and honored.
63
64. www.duanemorris.com
Privacy and Security, Social Media
• What is ‘social media’?
– Forms of exchange of user-generated content,
including blogging, chat rooms, internet forums,
podcasts, instant messaging, etc.
• Principle is free-flow of information (and thus difficult
to control privacy and security).
• No separate laws (yet).
• If mHealth product/service uses social media (e.g., an
app that links to a chat room), must ensure
transparency of how data used, obtained consent as
necessary, etc.
64
65. www.duanemorris.com
Privacy and Security, Other Resources
• HHS’s Office of National Coordinator
www.healthit.gov (authorized by ARRA to
oversee development of HIT):
– Development of Nationwide Privacy and Security
Framework for National Health Information Exchange
(HIE)
Privacy and security at every level.
– Examining conflicting state laws around consent.
– Developing toolkits.
65
66. www.duanemorris.com
Privacy and Security,
Recommendations
• To determine best industry privacy and security
practices, work with industry groups, consultants.
• General resources:
– mHIMSS, www.mhimss.org
– AHIMA, www.ahima.org
• Obtain legal advice regarding applicable laws (HIPAA,
FTC, sensitive data, breach, etc.) and whether the
product/service’s privacy and security compliance
program satisfies those laws.
66